Combating Meth and Cocaine Act

Bill: 116-hr-4111
Sponsor: full_name: Rep. Gibbs, Bob [R-OH-7]
Introduced: 2019-07-30
Policy area: Health
Subjects: Drug trafficking and controlled substances

Drug, alcohol, tobacco use

Health programs administration and funding

Health promotion and preventive care

Medical tests and diagnostic methods

Mental health

Prescription drugs
Latest action: action_date: 2019-07-31
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2019-07-30
action_desc: Introduced in House
text: <p><b>Combating Meth and Cocaine Act</b><br /><br />This bill authorizes the Substance Abuse and Mental Health Services Administration to award grants to states for the treatment and prevention of opioid-use disorders. Funds may be used for activities including education, treatment, and medical screenings related to opioid-use disorders, as well as for referrals to behavioral health services and recovery support. Grants also may be used to prevent or treat&nbsp;cocaine- or&nbsp;methamphetamine-use disorders. </p>

tv_txt: I 116th CONGRESS 1st Session H. R. 4111 IN THE HOUSE OF REPRESENTATIVES July 30, 2019 Mr. Gibbs (for himself and Mr. Ryan ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To authorize State opioid response grants, and for other purposes.

1. Short title This Act may be cited as the Combating Meth and Cocaine Act . 2. State opioid response grants (a) Authorization The Assistant Secretary for Mental Health and Substance Use may award opioid response grants to States. (b) Prevention and treatment activities A State may use the funds awarded through a grant under subsection (a) to carry out prevention and treatment activities with respect to opioid use disorders, which may include— (1) education regarding opioid use disorders; (2) treatment (including the provision of medication) for opioid use disorders; (3) behavioral health services for individuals in opioid treatment programs; (4) referral to treatment services for individuals with an opioid use disorder; (5) recovery support for individuals with an opioid use disorder; (6) medical screening associated with such treatment; and (7) preventing or treating the abuse of psychostimulants, such as cocaine or methamphetamine. (c) Authorization of appropriations There is authorized to be appropriated $500,000,000 for each of fiscal years 2020 through 2024 for the purpose of carrying out this section.